EVOFEM BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
EVOFEM BIOSCIENCES, INC. (EVFM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 30 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-03-11
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-12-31 was 229.16K shares.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-09-30 was 88.78K shares, a 47.48% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-06-30 was 87.36K shares, a 36.55% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-03-31 was 1.55K shares, a 99.56% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 30.00 shares, a 92.00% decline from fiscal 2024.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 375.00 shares, a 80.52% decline from fiscal 2023.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.93K shares, a 99.27% decline from fiscal 2022.
- EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 262.33K shares, a 82.73% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 30.00 shares 10-K · filed 2026-03-11 | |||
| 2024-12-31 | 375.00 shares 10-K · filed 2025-03-24 | |||
| 2023-12-31 | 1.93K shares 10-K · filed 2024-03-27 | |||
| 2022-12-31 | 262.33K shares 10-K · filed 2023-04-27 | |||
| 2021-12-31 | 1.52M shares 10-K · filed 2022-03-10 | |||
| 2017-12-31 | 229.16K shares derived: 8-K/A 12 month − 10-Q 9 month · filed 2018-04-06 | 317.94K shares derived: sum of 2 quarters · filed 2018-04-06 | 405.30K shares derived: sum of 3 quarters · filed 2018-04-06 | 406.84K shares 8-K/A · filed 2018-04-06 |
| 2017-09-30 | 88.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 176.13K shares derived: sum of 2 quarters · filed 2017-11-08 | 177.68K shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 87.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 88.90K shares 10-Q · filed 2017-08-10 | ||
| 2017-03-31 | 1.55K shares 10-Q · filed 2017-05-11 | |||
| 2016-09-30 | 169.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 306.72K shares derived: sum of 2 quarters · filed 2016-11-10 | 657.49K shares 10-Q · filed 2016-11-10 | |
| 2016-06-30 | 137.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 488.45K shares 10-Q · filed 2016-08-11 | ||
| 2016-03-31 | 350.77K shares 10-Q · filed 2016-05-12 | |||
| 2015-09-30 | 45.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 57.02K shares 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | 11.45K shares 10-Q · filed 2015-08-13 |